MusclePharm Corporation (MSLP)

0.2200 +0.0290 (+15.18%) At close: 03:34PM EDT

MusclePharm Corporation

6728 West Sunset Road
Suite 130
Las Vegas, NV 89119
United States
800 859 3010
https://www.musclepharm.com

Sector(s): Consumer Defensive
Industry: Packaged Foods
Full Time Employees: 21

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Ryan Charles Drexler	Exec. Chairman & CEO	1.64M	N/A	1971
Ms. Sabina Rizvi	Pres, CFO & Director	420.35k	N/A	1968
John Mills Mills	Sr. Managing Director	N/A	N/A	N/A
Dr. Roscoe M. Moore Jr., DSc, DVM, MPH, Ph.D.	Chief Scientific Director & Member of Scientific Advisory Board	N/A	N/A	1945
Mr. Mark E. Groussman	Consultant	N/A	N/A	1973

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

Corporate Governance

MusclePharm Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.